The Journal of allergy and clinical immunology
CCL5 is a Potential Bridge Between Type-1 and Type-2 Inflammation in Asthma.
Multi-omic approach associates blood methylome with bronchodilator drug response in pediatric asthma.
Bronchial Epithelial Cell Transcriptional Responses to Inhaled Corticosteroids Dictate Severe Asthmatic Outcomes.
Interleukin-13 associated epithelial remodeling correlates with clinical severity in nasal polyposis.
Multiomics analysis identifies BIRC3 as a novel glucocorticoid response-associated gene.
Racial/ethnic differences in eligibility for asthma biologics among pediatric populations.
Metabolome subtyping of severe bronchiolitis in infancy and risk of childhood asthma.
PrecISE: Precision Medicine in Severe Asthma An Adaptive Platform Trial with Biomarker Ascertainment.
Quantitative CT metrics are associated with longitudinal lung function decline and future asthma exacerbations: results from SARP-3.
NLRP1 variant M1184V decreases inflammasome activation in the context of DPP9 inhibition and asthma severity.
